Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Incyte Corp (NASDAQ:INCY) with a Buy rating and announced a price target of $135. Incyte shares closed at $102.60 on Wednesday. See how other analysts view this stock.
- Benchmark analyst Todd M. Brooks initiated coverage on CAVA Group, Inc. (NYSE:CAVA) with a Buy rating and announced a price target of $80. Cava shares closed at $65.41 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Yanni Souroutzidis initiated coverage on Karyopharm Therapeutics Inc. (NASDAQ:KPTI) with an Overweight rating. Karyopharm Therapeutics shares closed at $6.30 on Wednesday. See how other analysts view this stock.
- Benchmark analyst Ben Klieve initiated coverage on The Andersons, Inc. (NASDAQ:ANDE) with a Buy rating and announced a price target of $75. Andersons shares closed at $64.67 on Wednesday. See how other analysts view this stock.
Considering buying INCY stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments